BTZO - 1,>= 98%( HPLC )

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

BTZO-1 may be used in ARE-mediated gene expression studies.

Biochem/physiol Actions

BTZO-1 is a suppressor of cardiomyocyte apoptosis presumably by activation of antioxidant response element (ARE)-mediated gene expression. BTZO-1 binds to the macrophage migration inhibitory factor (MIF) that is required to activate the glutathione S-transferase Ya subunit (GST Ya) gene ARE.

Features and Benefits

This compound was developed by Takeda. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

5, 25 mg in glass bottle